abstract |
The present invention relates to furanopyrimidinone compounds useful for the treatment of cell proliferative diseases, the treatment of disorders associated with KSP kinesin activity, and the inhibition of KSP kinesin. The invention also relates to compositions containing these compounds and methods of using them for the treatment of cancer in mammals. |